You are here
P&T July 2014
FDA approvals, drug indications, and updates
Albiglutide (Tanzeum) for type-2 diabetes, ramucirumab (Cyramza) for advanced or metastatic gastric or gastro-esophageal junction adenocarcinoma, and ceritinib (Zykadia) for metastatic non–small-cell lung cancer
The American Society of Clinical Oncology meeting drew more than 34,600 people to Chicago to learn about the latest research, including studies on lymphoma, pancreatic cancer, colon cancer, melanoma, multiple myeloma, and palliative care.